O QUE O JEJUM INTERMITENTE TEM A DIZER SOBRE CÂNCER, SAÚDE CARDIOVASCULAR E SAÚDE CÉREBRO-MENTAL

Autores

DOI:

https://doi.org/10.47820/recima21.v4i1.2638

Palavras-chave:

Jejum intermitente, Câncer, Disfunção cognitiva

Resumo

INTRODUÇÃO: O jejum intermitente é uma estratégia nutricional em que se intercala períodos de jejum com períodos de alimentação visando à promoção de saúde. O presente estudo investiga se essa prática promove efeitos benéficos na saúde cardiovascular, cérebro-mental e no tratamento do câncer. MÉTODOS: Foi realizado levantamento de dados a partir de busca em banco de dados eletrônicos. Utilizou-se como descritores: Jejum intermitente; Disfunção Cognitiva; Câncer. Foram selecionados periódicos de categoria superior a B3, utilizando como critério artigos submetidos entre 2016 e 2019. Como critérios de exclusão, os artigos que não apresentaram desfecho com jejum intermitente ou que utilizaram outros animais que não fossem camundongos ou humanos foram excluídos da análise. RESULTADOS: O jejum intermitente se mostrou aliado eficiente no tratamento contra o câncer pelo seu efeito potencializador no tratamento quimioterápico, diminuindo o avanço da doença, além disso foi observado redução nos parâmetros de risco cardiovascular em indivíduos sob restrição calórica ao mesmo tempo em que se observou melhora no desempenho cognitivo. CONCLUSÃO: Em conclusão, o jejum intermitente se mostrou aliado eficaz no tratamento do câncer ao retardar sua progressão bem como na promoção de saúde a partir dos ganhos na saúde cardiovascular e cérebro-mental.

Downloads

Não há dados estatísticos.

Biografia do Autor

Ray Braga Romero, Universidade José do Rosário Vellano/Alfenas -MG.

Universidade José do Rosário Vellano/Alfenas -MG.

 

Carollayne Mendonça Rocha, Universidade José do Rosário Vellano/Alfenas -MG

Universidade José do Rosário Vellano/Alfenas -MG.

Sérgio Antônio Murad Neto, Universidade José do Rosário Vellano/Alfenas -MG

Universidade José do Rosário Vellano/Alfenas -MG.

Gabriel Henrique Ferracioli Alvarenga, Universidade José do Rosário Vellano/Alfenas

Universidade José do Rosário Vellano/Alfenas -MG.

Rodrigo Borges Cruz, Universidade José do Rosário Vellano/Alfenas -MG

Universidade José do Rosário Vellano/Alfenas -MG.

Lethícia Fernandes Jorge, Universidade José do Rosário Vellano/Alfenas -MG

Universidade José do Rosário Vellano/Alfenas -MG.

Alessandra Cristina Pupin Silvério, Universidade José do Rosário Vellano/Alfenas -MG

Universidade José do Rosário Vellano/Alfenas -MG.

Referências

AMARAVADI, Ravi; KIMMELMAN, Alec C.; WHITE, Eileen. Recent insights into the function of autophagy in cancer. Genes & Development. [s.l.], v.30, n.17, p. 1913-1930, Set/Set. 2016.

ANTONI, Rona et al. Effects of intermittent fasting on glucose and lipid metabolism. Proceedings Of The Nutrition Society. Cambridge, v.76, n.3, p. 361-368, Jan/Ago. 2017.

ANTONI, Rona et al. Investigation into the acute effects of total and partial energy restriction on postprandial metabolism among overweight/obese participants. British Journal Of Nutrition. [s.l.], v.115, n.6, p. 951-959, Mar. 2016.

ANTUNES, Fernanda et al. Autophagy and intermittent fasting: the connection for cancer therapy?. Clinics. São Paulo, v.73, n. supl 1, p. e814s, Mai/Set. 2018.

BOUTANT, Marie et al. SIRT1 Gain of Function Does Not Mimic or Enhance the Adaptations to Intermittent Fasting. Cell Reports. [s.l.], v.14, n.9, p. 2068-2075, Mar. 2016.

CATENACCI, Victoria A. et al. A randomized pilot study comparing zero-calorie alternate-day fasting to daily caloric restriction in adults with obesity. Obesity (silver Spring). [s.l.], v.24, n.9, p. 1874-1883, Set. 2016.

CHENG, Aiwu et al. Mitochondrial SIRT3 Mediates Adaptive Responses of Neurons to Exercise, and Metabolic and Excitatory Challenges. Cell Metabolism. [s.l.], v.23, n.1, p. 128-142, Jan. 2016.

CIGNARELLA, Francesca et al. Intermittent Fasting Confers Protection in CNS Autoimmunity by Altering the Gut Microbiota. Cell Metabolism. [s.l.], v.27, n.6, p. 1222-1235, Jan. 2018.

CORLEY, B. T. et al. Intermittent fasting in Type 2 diabetes mellitus and the risk of hypoglycaemia: a randomized controlled trial. Diabetic Medicine. Wellington, v.35, n.5, p. 588-594, Jan/Mai. 2018.

DORFF, Tanya B. et al. Safety and feasibility of fasting in combination with platinum-based chemotherapy. Bmc Cancer. [s.l.], v.16, n.360, p. 1-9, Jun. 2016.

FANN, David Yang-wei et al. Positive effects of intermittent fasting in ischemic stroke. Experimental Gerontology. Singapura, v.89, p. 93-102, Mar. 2017.

FASSIER, Philippine et al. Fasting and weight-loss restrictive diet practices among 2,700 cancer survivors: results from the NutriNet-Santé cohort. International Journal Of Cancer. Bobigny, France, v.143, n.11, p. 2687-2697, Jul/Dez. 2018.

FASSIER, Philippine et al. Sociodemographic and economic factors are associated with weight gain between before and after cancer diagnosis: results from the prospective population-based NutriNet-Santé cohort. Oncotarget. Bobigny, France, v.8, n.33, p. 54640-54653, Nov/Mai. 2017.

GALLUZZI, Lorenzo et al. Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles. Nature Reviews Drug Discovery. [s.l.], v.16, n.7, p. 487-511, Mai/Jul. 2017.

GIGLI, Rafael et al. The biphosphinic paladacycle complex induces melanoma cell death through lysosomal–mitochondrial axis modulation and impaired autophagy. European Journal Of Medicinal Chemistry. [s.l.], v.107, p. 245-254, Jan/Jan. 2016.

GRASSO, Silvina et al. Autophagy regulates Selumetinib (AZD6244) induced-apoptosis in colorectal cancer cells. European Journal Of Medicinal Chemistry. [s.l.], v.122, p. 611-618, Out. 2016.

GOTTHARDT, Juliet D. et al. Intermittent Fasting Promotes Fat Loss With Lean Mass Retention, Increased Hypothalamic Norepinephrine Content, and Increased Neuropeptide Y Gene Expression in Diet-Induced Obese Male Mice. Endocrinology. [s.l.], v.157, n.2, p. 679-691, Fev. 2016.

HARVIE, Michelle N; HOWELL, Tony. Could Intermittent Energy Restriction and Intermittent Fasting Reduce Rates of Cancer in Obese, Overweight, and Normal-Weight Subjects? A Summary of Evidence. Advances In Nutrition. [s.l.], v.7, n.4, p. 690-705, Jul. 2016.

HARVIE, Michelle N. et al. Intermittent energy restriction induces changes in breast gene expression and systemic metabolism. Breast Cancer Research. [s.l.], v.18, n.1, p. 57, Mai. 2016.

JOSLIN, P. M. N.; BELL, R. K.; SWOAP, S. J.. Obese mice on a high-fat alternate-day fasting regimen lose weight and improve glucose tolerance. Journal Of Animal Physiology And Animal Nutrition (Berl). [s.l.], v.101, n.5, p. 1036-1045, Out. 2017.

KIM, Kyoung-han et al. Intermittent fasting promotes adipose thermogenesis and metabolic homeostasis via VEGF-mediated alternative activation of macrophage. Cell Research. [s.l.], v.27, n.11, p. 1309-1326, Nov. 2017.

LEVY, Jean M. Mulcahy; TOWERS, Christina G.; THORBURN, Andrew. Targeting autophagy in cancer. Nature Reviews Cancer. [s.l.], v.17, n.9, p. 528-542, Jul. 2017.

LI, Guolin et al. Intermittent Fasting Promotes White Adipose Browning and Decreases Obesity by Shaping the Gut Microbiota. Cell Metabolism. [s.l.], v.26, n.4, p. 672-685, Out. 2017.

LIU, Xiangyu et al. Inhibition of Autophagy by Chloroquine Enhances the Antitumor Efficacy of Sorafenib in Glioblastoma. Cellular And Molecular Neurobiology. [s.l.], v.36, p. 1197-1208, Mar/Out. 2016.

LIU, Bo et al. Intermittent fasting increases energy expenditure and promotes adipose tissue browning in mice. Nutrition. Adelaide, v.66, p. 38-43, Dez/Out. 2019.

MARTEL, Cécile et al. Knockdown of angiopoietin-like 2 mimics the benefits of intermittent fasting on insulin responsiveness and weight loss. Experimental Biology And Medicine. Montreal, v.243, p. 45-49, Set/Nov. 2018.

MATTSON, Mark P.; LONGO, Valter D.; HARVIED, Michelle. Impact of intermittent fasting on health and disease processes. Ageing Research Reviews. [s.l.], v.39, p. 46-58, Out. 2017.

MORO, Tatiana et al. Effects of eight weeks of time-restricted feeding (16/8) on basal metabolism, maximal strength, body composition, inflammation, and cardiovascular risk factors in resistance-trained males. Journal Of Translational Medicine. [s.l.], v.14, n.1, p. 290, Out. 2016.

O’FLANAGAN, Ciara H. et al. When less may be more: calorie restriction and response to cancer therapy. Bmc Medicine. [s.l.], v.15, n.1, p. 1-9, Mai. 2017.

PATTERSON, Ruth e; DOROTHY, D Sears. Metabolic Effects of Intermittent Fasting. Annual review of nutrition vol. 37 (2017): 371-393.

PIETROCOLA, Federico et al. Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance. Cancer Cell. [s.l.], v.30, n.1, p. 147-160, Jul. 2016.

POTTER, Gregory D M et al. Nutrition and the circadian system. British Journal Of Nutrition. [s.l.], v.116, n.3, p. 434-442, Ago. 2016.

RE, Oriana Lo et al. Fasting inhibits hepatic stellate cells activation and potentiates anti‐cancer activity of Sorafenib in hepatocellular cancer cells. Journal Of Cellular Physiology. [s.l.], v.233, n.2, p. 1202-1212, Fev. 2018.

SHARIFI, Marina N. et al. Autophagy Promotes Focal Adhesion Disassembly and Cell Motility of Metastatic Tumor Cells through the Direct Interaction of Paxillin with LC3. Cell Reports. [s.l.], v.15, n.8, p. 1660-1672, Mai. 2016.

SHIN, Bae Kun et al. Intermittent fasting protects against the deterioration of cognitive function, energy metabolism and dyslipidemia in Alzheimer’s disease-induced estrogen deficient rats. Experimental Biology And Medicine. Asan, v.243, p. 334-343, Set/Dez. 2018.

ST-ONGE, Marie-pierre et al. Meal Timing and Frequency: Implications for Cardiovascular Disease Prevention: A Scientific Statement From the American Heart Association. Circulation. [s.l.], v.135, n.9, p. e96-e121, Fev. 2017.

SILVA LIMA, C. L.; SALMITO, P. A.; ARAÚJO, L. DA S.; LIRA, S. M.; DA SILVA, J. Y. G.; HOLANDA, M. O.; PAIM, R. T. T.; GIRÃO, N. M. Jejum intermitente no emagrecimento: uma revisão sistemática. RBNE - Revista Brasileira de Nutrição Esportiva, v. 13, n. 79, p. 426-436, 9 set. 2019.

SUN, Pengfei et al. Fasting inhibits colorectal cancer growth by reducing M2 polarization of tumor-associated macrophages. Oncotarget. [s.l.], v.8, n.43, p. 74649-74660, Mai/Ago. 2017.

TREPANOWSKI, John F; BLOOMER, Richard J. The impact of religious fasting on human health. Nutrition journal v. 9 n.57. Nov. 2010.

TINSLEY, Grant M.; HORNE, Benjamin D.. Intermittent fasting and cardiovascular disease: current evidence and unresolved questions. Future Cardiol. [s.l.], v.14, n.1, p. 47-54, Abr/Dez. 2017.

TINSLEY, Grant M. et al. Time-restricted feeding in young men performing resistance training: A randomized controlled trial. European Journal Of Sport Science. [s.l.], v.17, n.2, p. 200-207, Mar. 2017.

XIE, K., et al. Every-other-day feeding extends lifes pan but fails to delay many symptoms of aging in mice. Nature Communications. [s.l.], v.8, n.1, p. 155, Jul. 2017.

YANG, Wanwei et al. Alternate-day fasting protects the livers of mice against high-fat diet-induced inflammation associated with the suppression of Toll-like receptor 4/nuclear factor κB signaling. Nutrition Research. [s.l.], v.36, n.6, p. 586-593, Jun. 2016.

ZUO, Li et al. Comparison of High-Protein, Intermittent Fasting Low-Calorie Diet and Heart Healthy Diet for Vascular Health of the Obese. Frontiers In Physiology. [s.l.], v.7, p. 350, Ago. 2016.

Downloads

Publicado

27/01/2023

Como Citar

Braga Romero, R., Mendonça Rocha, C. ., Murad Neto, S. A., Ferracioli Alvarenga, G. H., Borges Cruz, R. ., Fernandes Jorge, L., & Pupin Silvério, A. C. (2023). O QUE O JEJUM INTERMITENTE TEM A DIZER SOBRE CÂNCER, SAÚDE CARDIOVASCULAR E SAÚDE CÉREBRO-MENTAL. RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218, 4(1), e412638. https://doi.org/10.47820/recima21.v4i1.2638